Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008-Reference-Cited by-同舟云学术

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008

Published:2013-04-11 Issue:15 Volume:121 Page:2996-3004
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Morton Lindsay M.¹,Dores Graça M.¹²,Tucker Margaret A.¹,Kim Clara J.¹,Onel Kenan³,Gilbert Ethel S.¹,Fraumeni Joseph F.¹,Curtis Rochelle E.¹

Affiliation:

1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD;

2. Department of Veterans Affairs Medical Center, Oklahoma City, OK; and

3. Department of Pediatrics, University of Chicago, Chicago, IL

Abstract

Key Points Coincident with major changes in cancer treatments, the occurrence of tAML has changed significantly with time. The risks for tAML should be weighed against the benefits of chemotherapy.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/15/2996/1365270/2996.pdf

Reference49 articles.

1. Howlader N Noone A Krapcho M SEER Cancer Statistics Review, 1975-2009, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009/; 2012

2. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report.;Rowley;Genes Chromosomes Cancer,2002

3. Therapy-related myeloid leukemia.;Godley;Semin Oncol,2008

4. Therapy-related myeloid neoplasms.;Czader;Am J Clin Pathol,2009

5. Incidence and susceptibility to therapy-related myeloid neoplasms.;Leone;Chem Biol Interact,2010

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric therapy-related hematologic neoplasms show enrichment for KMT2A rearrangement and lymphoblastic phenotype;Leukemia & Lymphoma;2024-08-08

2. Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML;European Journal of Haematology;2024-08-08

3. Survival Outcomes and Prognostic Factors in Therapy-Related Acute Myeloid Leukemia: A SEER Database Study, 2000-2020;Clinical Lymphoma Myeloma and Leukemia;2024-07

4. Subsequent Malignancies After CD19-Targeted Chimeric Antigen Receptor T Cells in Patients With Lymphoma;Transplantation and Cellular Therapy;2024-07

5. Rare NUP98::PRRX1 fusion transcript in a therapy-related acute myeloid leukemia associated with del(7q) following chemotherapy for diffuse large B-cell lymphoma;Cancer Genetics;2024-06